🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Daniel O. Scharfstein

University of Utah

ORCID: 0000-0001-7482-9653
MathematicsEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes”.

Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes

Biometrics(2020)10.1111/biom.13377
N/A
0DataRank · unranked
73 citations

Iván Díaz, Alex Luedtke, Jodi B Segal, Daniel O. Scharfstein, Michael Rosenblum +1 more

A Bayesian nonparametric approach for evaluating the causal effect of treatment in randomized trials with semi-competing risks

Biostatistics(2020)10.1093/biostatistics/kxaa008
N/A
0DataRank · unranked
19 citations

Daniel O. Scharfstein, Peter Müller, Michael J. Daniels, Yanxun Xu

Improving Precision and Power in Randomized Trials for COVID-19 Treatments Using Covariate Adjustment, for Binary, Ordinal, and Time-to-Event Outcomes

medRxiv(2020)10.1101/2020.04.19.20069922
N/A
0DataRank · unranked
14 citations

Iván Díaz, Alex Luedtke, Jodi B Segal, Daniel O. Scharfstein, Michael Rosenblum +1 more

Rejoinder: Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes

Biometrics(2021)10.1111/biom.13495
N/A
0DataRank · unranked
2 citations

Iván Díaz, Alex Luedtke, Jodi B Segal, Daniel O. Scharfstein, Michael Rosenblum +1 more

Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.20680
N/A
0DataRank · unranked
17 citations

Zachary A. Marcum, Chong Zhang, Catherine G. Derington, Tom Greene, Lama Ghazi +12 more

Randomized Trials With Repeatedly Measured Outcomes: Handling Irregular and Potentially Informative Assessment Times

Epidemiologic Reviews(2022)10.1093/epirev/mxac010
N/A
0DataRank · unranked
14 citations

Daniel O. Scharfstein, Eleanor Pullenayegum

Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis

PLoS ONE(2022)10.1371/journal.pone.0273526
N/A
0DataRank · unranked
11 citations

Elizabeth L. Ogburn, Malathi Ram, Daniel O. Scharfstein, Tianjing Li, P Khanal +23 more

Semi-Parametric Sensitivity Analysis for Trials with Irregular and Informative Assessment Times

arXiv (Cornell University)(2022)10.48550/arxiv.2204.11979
N/A
0DataRank · unranked
1 citations

Gao, Yujing, Shu Yang, Varadhan, Ravi, Andrea J. Apter, Daniel O. Scharfstein +1 more

Losartan in hospitalized patients with COVID-19 in North America: An individual participant data meta-analysis

Medicine(2023)10.1097/md.0000000000033904
N/A
0DataRank · unranked
3 citations

Malathi Ram, Daniel O. Scharfstein, Tianjing Li, P Khanal, Sheriza Baksh +13 more

Sensitivity analysis for principal ignorability violation in estimating complier and noncomplier average causal effects

arXiv (Cornell University)(2023)10.48550/arxiv.2303.05032
N/A
0DataRank · unranked
1 citations

Elizabeth A. Stuart, Daniel O. Scharfstein, Elizabeth L. Ogburn, Trang Quynh Nguyen

Sensitivity analysis for principal ignorability violation in estimating complier and noncomplier average causal effects

Statistics in Medicine(2024)10.1002/sim.10153
N/A
0DataRank · unranked
4 citations

Elizabeth A. Stuart, Daniel O. Scharfstein, Elizabeth L. Ogburn, Trang Quynh Nguyen

Semi-parametric sensitivity analysis for trials with irregular and informative assessment times

Biometrics(2024)10.1093/biomtc/ujae154
N/A
0DataRank · unranked
3 citations

Yujing Gao, Shu Yang, Ravi Varadhan, Andrea J. Apter, Daniel O. Scharfstein +1 more

Effect of Initiation and Continuous Adherence to ARBs Versus ACEIs on Risk of Adjudicated Mild Cognitive Impairment or Dementia

The Journals of Gerontology Series A(2025)10.1093/gerona/glaf028
N/A
0DataRank · unranked
7 citations

Ransmond O. Berchie, Daniel O. Scharfstein, Ryan M. Andrews, Tom Greene, Yizhe Xu +9 more

Psychometric properties of the knee osteoarthritis pain index

Pain Medicine(2025)10.1093/pm/pnaf067
N/A
0DataRank · unranked
1 citations

Timothy R. Fleagle, Elena D. Staguhn, Daniel O. Scharfstein, Rachel V. Aaron, Steven P. Cohen +9 more

Off-schedule patient-reported outcomes in adults with asthma may influence research results

Journal of Allergy and Clinical Immunology(2025)10.1016/j.jaci.2025.04.024
N/A
0DataRank · unranked
0 citations

Heather Klusaritz, Tyra Bryant-Stephens, A. Russell Localio, Daniel O. Scharfstein, Kadel La Rose +7 more

Study design and protocol of a randomized, pragmatic, comparative effectiveness trial evaluating a sequenced strategy for improving outcomes in people with knee osteoarthritis pain (SKOAP): Conservative treatment evaluation

Seminars in Arthritis and Rheumatism(2025)10.1016/j.semarthrit.2025.152834
N/A
0DataRank · unranked
0 citations

Melinda M. Holena, Lauren Allen, SiNing Zhao, R. Castillo, Steven P. Cohen +13 more